Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Susmita Pandey, Ingeborg Bolstad, Lars Lien & Jørgen G Bramness. (2021) Antisocial Personality Disorder Among Patients in Treatment for Alcohol Use Disorder (AUD): Characteristics and Predictors of Early Relapse or Drop-Out. Substance Abuse and Rehabilitation 12, pages 11-22.
Read now
Read now
Maurizio Coppola & Raffaella Mondola. (2018) Impulsivity in Alcohol-Dependent Patients with and without ADHD: The Role of Atomoxetine. Journal of Psychoactive Drugs 50:4, pages 361-366.
Read now
Read now
David B Clemow, Chris Bushe, Michele Mancini, Michael H Ossipov & Himanshu Upadhyaya. (2017) A review of the efficacy of atomoxetine in the treatment of attention-deficit hyperactivity disorder in children and adult patients with common comorbidities. Neuropsychiatric Disease and Treatment 13, pages 357-371.
Read now
Read now
Daniel J Walker, Oren Mason, David B Clemow & Kathleen A Day. (2015) Atomoxetine treatment in adults with attention-deficit/hyperactivity disorder. Postgraduate Medicine 127:7, pages 686-701.
Read now
Read now
Giulio Perugi & Giulia Vannucchi. (2015) The use of stimulants and atomoxetine in adults with comorbid ADHD and bipolar disorder. Expert Opinion on Pharmacotherapy 16:14, pages 2193-2204.
Read now
Read now
Articles from other publishers (32)
Tsutomu Nagai, Tatsuya Kurihara, Hiroaki Koya, Yukako Nakano, Satoru Sugisawa, Takehiko Sambe, Keiko Kishimoto, Mari Kogo, Haruhisa Ota, Akira Iwanami & Naoki Uchida. (2022)
Identification of factors associated with the efficacy of atomoxetine in adult
attention‐deficit
/hyperactivity disorder
. Neuropsychopharmacology Reports 42:3, pages 249-255.
Crossref
Crossref
Daria Taubin, Julia C. Wilson & Timothy E. Wilens. (2022) ADHD and Substance Use Disorders in Young People. Child and Adolescent Psychiatric Clinics of North America 31:3, pages 515-530.
Crossref
Crossref
Luis M. García-Marín, Adrián I. Campos, Gabriel Cuéllar-Partida, Sarah E. Medland, Scott H. Kollins & Miguel E. Rentería. (2021) Large-scale genetic investigation reveals genetic liability to multiple complex traits influencing a higher risk of ADHD. Scientific Reports 11:1.
Crossref
Crossref
Alexandra P. Lam, Sebastian Moeller, Christine Speitling, Martin C. Lam, Alexandra Philipsen & Helge H. O. Müller. (2020) Consumption of Synthetic Cannabinoids in Adult Attention-Deficit/Hyperactivity Disorder: a Pilot Study. International Journal of Mental Health and Addiction 19:5, pages 1586-1604.
Crossref
Crossref
Dimy Fluyau, Neelambika Revadigar & Christopher G. Pierre. (2020) Systematic Review and Meta‐Analysis: Treatment of Substance Use Disorder in Attention Deficit Hyperactivity Disorder. The American Journal on Addictions 30:2, pages 110-121.
Crossref
Crossref
Kathleen T. Brady, Frances R. Levin, Marc Galanter & Herbert D. KleberTimothy Wilens & Tamar Kaminski. 2021. The American Psychiatric Association Publishing Textbook of Substance Use Disorder Treatment. The American Psychiatric Association Publishing Textbook of Substance Use Disorder Treatment.
NaveenKumar Dhagudu, Mayurnath Reddy & Omesh Kumar. (2021) Prevalence and profile of adult attention deficit hyperactive disorder in alcohol use disorder: An explorative study. Telangana Journal of Psychiatry 7:2, pages 94.
Crossref
Crossref
Joe Johnson, Sarah Morris & Sanju George. (2021) Managing Comorbid Attention Deficit Hyperactivity Disorder (ADHD) in Adults With Substance Use Disorder (SUD): What the Addiction Specialist Needs to Know. Addictive Disorders & Their Treatment 20:3, pages 181-188.
Crossref
Crossref
Susan Young, Rafael A. González, Kim Wolff, Kiriakos Xenitidis, Laura Mutch, Isabella Malet-Lambert & Gisli H. Gudjonsson. (2017) Substance and Alcohol Misuse, Drug Pathways, and Offending Behaviors in Association With ADHD in Prison Inmates. Journal of Attention Disorders 24:13, pages 1905-1913.
Crossref
Crossref
Michelle J. Zaso, Aesoon Park & Kevin M. Antshel. (2015) Treatments for Adolescents With Comorbid ADHD and Substance Use Disorder: A Systematic Review. Journal of Attention Disorders 24:9, pages 1215-1226.
Crossref
Crossref
Wilco Sliedrecht, Ranne de Waart, Katie Witkiewitz & Hendrik G. Roozen. (2019) Alcohol use disorder relapse factors: A systematic review. Psychiatry Research 278, pages 97-115.
Crossref
Crossref
Federico Mucci, Maria Teresa Avella & Donatella Marazziti. (2019) ADHD with Comorbid Bipolar Disorders: A Systematic Review of Neurobiological, Clinical and Pharmacological Aspects Across the Lifespan. Current Medicinal Chemistry 26:38, pages 6942-6969.
Crossref
Crossref
Katelijne van Emmerik-van Oortmerssen, Ellen Vedel, Floor J. Kramer, Maarten W. Koeter, Robert A. Schoevers & Wim van den Brink. (2017) Diagnosing ADHD during active substance use: Feasible or flawed?. Drug and Alcohol Dependence 180, pages 371-375.
Crossref
Crossref
Vinutha Ravishankar, Suresh Vedaveni Chowdappa, Vivek Benegal & Kesavan Muralidharan. (2016) The efficacy of atomoxetine in treating adult attention deficit hyperactivity disorder (ADHD): A meta-analysis of controlled trials. Asian Journal of Psychiatry 24, pages 53-58.
Crossref
Crossref
Shari L. Hutchison, Jaswinder K. Ghuman, Harinder S. Ghuman, Irina Karpov & James M. Schuster. (2016) Efficacy of atomoxetine in the treatment of attention-deficit hyperactivity disorder in patients with common comorbidities in children, adolescents and adults: a review. Therapeutic Advances in Psychopharmacology 6:5, pages 317-334.
Crossref
Crossref
Chris Bushe, Kathleen Day, Victoria Reed, Kristina Karlsdotter, Lovisa Berggren, Ashley Pitcher, Foula Televantou & Virginia Haynes. (2016) A network meta-analysis of atomoxetine and osmotic release oral system methylphenidate in the treatment of attention-deficit/hyperactivity disorder in adult patients. Journal of Psychopharmacology 30:5, pages 444-458.
Crossref
Crossref
Chris Bushe, Esther Sobanski, David Coghill, Lovisa Berggren, Katrien De Bruyckere & Sami Leppämäki. (2016) Post Hoc Analysis of Potential Predictors of Response to Atomoxetine for the Treatment of Adults with Attention-Deficit/Hyperactivity Disorder using an Integrated Database. CNS Drugs 30:4, pages 317-334.
Crossref
Crossref
Nicholas Carrellas, Timothy E. Wilens & Rayce Anselmo. (2016) Treatment of Comorbid Substance Use Disorders and ADHD in Youth. Current Treatment Options in Psychiatry 3:1, pages 15-27.
Crossref
Crossref
Marilyn E. Carroll & John R. Smethells. (2016) Sex Differences in Behavioral Dyscontrol: Role in Drug Addiction and Novel Treatments. Frontiers in Psychiatry 6.
Crossref
Crossref
Xanthe M. Barkla, Paul A. McArdle & Dorothy Newbury-Birch. (2015) Are there any potentially dangerous pharmacological effects of combining ADHD medication with alcohol and drugs of abuse? A systematic review of the literature. BMC Psychiatry 15:1.
Crossref
Crossref
E. Sobanski, S. Leppämäki, C. Bushe, L. Berggren, M. Casillas & W. Deberdt. (2015) Patterns of long-term and short-term responses in adult patients with attention-deficit/hyperactivity disorder in a completer cohort of 12 weeks or more with atomoxetine. European Psychiatry 30:8, pages 1011-1020.
Crossref
Crossref
Samira Groß & Alexandra Philipsen. (2015) Konzeptualisierung der Psychotherapie bei ADHS und Sucht. SUCHT 61:5, pages 311-318.
Crossref
Crossref
Nienke Broos, Rhianne Loonstra, Yvar van Mourik, Dustin Schetters, Anton N. M. Schoffelmeer, Tommy Pattij & Taco J. De Vries. (2015) Subchronic administration of atomoxetine causes an enduring reduction in context-induced relapse to cocaine seeking without affecting impulsive decision making. Addiction Biology 20:4, pages 714-723.
Crossref
Crossref
Jeffrey H Newcorn, Iliyan Ivanov & Anil Chacko. (2015) Recent Progress in Psychosocial and Psychopharmacologic Treatments for ADHD. Current Treatment Options in Psychiatry 2:1, pages 14-27.
Crossref
Crossref
Natalie E. Zlebnik & Marilyn E. Carroll. (2014) Effects of the combination of wheel running and atomoxetine on cue- and cocaine-primed reinstatement in rats selected for high or low impulsivity. Psychopharmacology 232:6, pages 1049-1059.
Crossref
Crossref
Juan D. Pedraza & Jeffrey H. Newcorn. 2015. Attention-Deficit Hyperactivity Disorder in Adults and Children. Attention-Deficit Hyperactivity Disorder in Adults and Children
259
275
.
Frieda Matthys, Steven Stes, Wim van den Brink, Peter Joostens, David Möbius, Sabine Tremmery & Bernard Sabbe. (2014) Guideline for Screening, Diagnosis and Treatment of ADHD in Adults with Substance Use Disorders. International Journal of Mental Health and Addiction 12:5, pages 629-647.
Crossref
Crossref
Philip Asherson, Chris Bushe, Keith Saylor, Yoko Tanaka, Walter Deberdt & Himanshu Upadhyaya. (2014) Efficacy of atomoxetine in adults with attention deficit hyperactivity disorder: An integrated analysis of the complete database of multicenter placebo-controlled trials. Journal of Psychopharmacology 28:9, pages 837-846.
Crossref
Crossref
Vivek Benegal, Biju Viswanath, Janardhanan C. Narayanaswamy, Sam P. Jose, Vaskar Chakraborty, Deepa Sankar, Thennarasu Kandavel & Muralidharan Kesavan. (2013) The efficacy of atomoxetine as adjunctive treatment for co-morbid substance use disorders and externalizing symptoms. Asian Journal of Psychiatry 6:6, pages 544-547.
Crossref
Crossref
Tommy Pattij & Taco J De Vries. (2013) The role of impulsivity in relapse vulnerability. Current Opinion in Neurobiology 23:4, pages 700-705.
Crossref
Crossref
Andrea Seitz, Manuela Wapp, Yuliya Burren, Sonja Stutz, Katrin Schläfli & Franz Moggi. (2013) Association between Craving and Attention Deficit/Hyperactivity Disorder Symptoms among Patients with Alcohol Use Disorders. The American Journal on Addictions 22:3, pages 292-296.
Crossref
Crossref
Himanshu P. Upadhyaya, Durisala Desaiah, Kory J. Schuh, Frank P. Bymaster, Mary J. Kallman, David O. Clarke, Todd M. Durell, Paula T. Trzepacz, David O. Calligaro, Eric S. Nisenbaum, Paul J. Emmerson, Leslie M. Schuh, Warren K. Bickel & Albert J. Allen. (2013) A review of the abuse potential assessment of atomoxetine: a nonstimulant medication for attention-deficit/hyperactivity disorder. Psychopharmacology 226:2, pages 189-200.
Crossref
Crossref